Chongqing Zhirui Investment Co., Ltd.

Chongqing Zhirui Investment Co., Ltd. (hereinafter referred to as "Zhirui Investment") is an equity investment company jointly established by Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "Zhifei Biological") and its controlling shareholder and actual controller Mr. Jiang Rensheng. Among them, Mr. Jiang Rensheng contributed RMB 90 million, accounting for 90%, and is the actual controller of Zhirui Investment; Zhifei Biological contributed RMB 10 million, accounting for 10%. Zhirui Investment will focus on relying on Zhirui Biomedical Industrial Park, and conduct external equity investment through holding or equity participation, mainly investing in companies engaged in biotechnology and product research and development that do not have horizontal competition with Zhifei Biological's existing vaccine business.
Zhirui Biomedical Industrial Park is a modern biomedical industrial park invested and constructed by Zhirui Investment Co., Ltd. (hereinafter referred to as "Zhirui Investment") in Chongqing Maliu Yanjiang Development Zone, integrating modernization, specialization, and high technology. The project covers an area of 525 mu, with phased investment and rolling development. The total construction area is 294,000 square meters, the plot ratio is 0.84, and the green space ratio is 37.87%. It is expected to be completed and fully put into production in 10-15 years.
Zhirui Investment takes as its fundamental goal "providing financial support and a good platform for people with lofty ideals in global biomedical research, attracting overseas Chinese with advanced international technology and excellent domestic teams to join Zhirui Biomedical Industrial Park, and promoting Zhirui Biomedical Industrial Park to achieve industrialization as soon as possible." It fully utilizes the advantages of the combination of capital and industry, comprehensively considers market development prospects, and on the basis of Zhifei Biological's existing traditional vaccine research and development and production technology, gives play to its independent research and development advantages and strengths, builds a new investment and research and development platform, and conducts research and development cultivation of promising biotechnology and products in the form of equity investment. At present, the project research and development progress is relatively smooth.
The Zhirui Biomedical Industrial Park project represents the world's advanced biopharmaceutical technology and conforms to the key development direction of our city's biomedical industry. After it is completed and put into production in the future, it will greatly supplement the field of high-end biopharmaceutical products in our city and effectively promote the leapfrog development of the local biomedical industry.